title: Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States.
abstract: Non-Hodgkin lymphoma arising in the context of immunosuppression is an important adverse outcome after solid organ transplantation. Diffuse large B-cell lymphoma (DLBCL) is the most commonly diagnosed subtype of post-transplantation non-Hodgkin lymphoma, but few studies of transplant recipients have examined subtype-specific risks. Therefore, we examined DLBCL risk in the Transplant Cancer Match Study, including registry-based cancer ascertainment among 96,615 solid organ transplants performed from 2000 to 2008. We determined standardized incidence ratios (SIRs) and 95% confidence intervals comparing DLBCL risk in transplant recipients with that in the general population, and used multivariable Poisson regression models to assess the impact of potential risk factors. We identified 321 incident cases of DLBCL, over 12 times more than expected based on general population rates (SIR = 12.6, 95% confidence interval = 11.2-14.0). SIRs were highest in young recipients and those receiving a lung or pancreas/kidney-pancreas transplant, and were greatly elevated for extranodal DLBCLs at the site of the transplantation compared with other sites. DLBCL risk was highest in the first year following transplantation, and SIRs for early-onset DLBCL risk were elevated in association with Epstein-Barr virus-negative serostatus and use of polyclonal antibody induction therapy. In conclusion, associations between recipient and transplant factors and post-transplantation DLBCL risk suggest a complicated interrelationship among multiple risk factors and timing of disease.
authors.affiliation: Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Cancer Prevention Fellowship Program, Division of Cancer Prevention, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
authors.forename: Todd M
authors.initials: TM
authors.lastname: Gibson
authors.forename: Eric A
authors.initials: EA
authors.lastname: Engels
authors.forename: Christina A
authors.initials: CA
authors.lastname: Clarke
authors.forename: Charles F
authors.initials: CF
authors.lastname: Lynch
authors.forename: Dennis D
authors.initials: DD
authors.lastname: Weisenburger
authors.forename: Lindsay M
authors.initials: LM
authors.lastname: Morton
mesh_terms: D000293:Adolescent; D000368:Aged; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D016403:Lymphoma, Large B-Cell, Diffuse / Q000453:epidemiology* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D016377:Organ Transplantation / Q000009:adverse effects / Q000706:statistics & numerical data*; D012307:Risk Factors; D014481:United States / Q000453:epidemiology; D055815:Young Adult
references.citation: Transplantation. 2009 Oct 27;88(8):962-7
references.pmid: 19855238
references.citation: JAMA. 2006 Dec 20;296(23):2823-31
references.pmid: 17179459
references.citation: Am J Transplant. 2006;6(5 Pt 2):1111-31
references.pmid: 16613591
references.citation: Transpl Infect Dis. 2001 Jun;3(2):60-9
references.pmid: 11395971
references.citation: Am J Hematol. 2011 Feb;86(2):206-9
references.pmid: 21264909
references.citation: Springer Semin Immunopathol. 1998;20(3-4):325-42
references.pmid: 9870249
references.citation: JAMA. 2011 Nov 2;306(17):1891-901
references.pmid: 22045767
references.citation: Am J Transplant. 2004 Feb;4(2):222-30
references.pmid: 14974943
references.citation: Transplantation. 2000 Mar 15;69(5):827-33
references.pmid: 10755535
references.citation: Am J Transplant. 2007 Apr;7(4):941-8
references.pmid: 17331115
references.citation: Br J Cancer. 2013 Jul 9;109(1):280-8
references.pmid: 23756857
references.citation: Br J Cancer. 2003 Oct 6;89(7):1221-7
references.pmid: 14520450
references.citation: Am J Transplant. 2013 Jun;13(6):1523-32
references.pmid: 23635036
references.citation: J Clin Oncol. 1998 Jun;16(6):2052-9
references.pmid: 9626203
references.citation: Lancet. 2007 Jul 7;370(9581):59-67
references.pmid: 17617273
references.citation: AIDS. 2006 Aug 1;20(12):1645-54
references.pmid: 16868446
references.citation: Am J Transplant. 2012 Mar;12(3):682-93
references.pmid: 22226336
references.citation: Am J Transplant. 2012 Apr;12(4):976-83
references.pmid: 22226225
references.citation: Radiology. 2002 Mar;222(3):699-708
references.pmid: 11867788
references.citation: Scand J Urol Nephrol. 1983;17(3):355-9
references.pmid: 6359387
references.citation: AJR Am J Roentgenol. 1998 Sep;171(3):725-31
references.pmid: 9725305
references.citation: Am J Pathol. 1995 Dec;147(6):1862-70
references.pmid: 7495309
references.citation: Lancet. 1993 Dec 18-25;342(8886-8887):1514-6
references.pmid: 7902900
references.citation: Radiat Res. 1993 May;134(2):134-42
references.pmid: 8488248
references.citation: Crit Rev Oncol Hematol. 2005 Oct;56(1):155-67
references.pmid: 15979320
references.citation: Blood. 2008 Dec 15;112(13):5150-60
references.pmid: 18796628
references.citation: Am J Hematol. 2013 Apr;88(4):245-50
references.pmid: 23386365
references.citation: J Clin Oncol. 1995 Apr;13(4):961-8
references.pmid: 7707124
references.citation: Transplantation. 2005 Nov 15;80(9):1233-43
references.pmid: 16314791
references.citation: Eur J Cancer. 2007 Sep;43(14):2117-23
references.pmid: 17764927
references.citation: N Engl J Med. 2004 Dec 23;351(26):2715-29
references.pmid: 15616206
references.citation: Blood. 2009 Jul 16;114(3):630-7
references.pmid: 19443660
references.citation: J Heart Lung Transplant. 1991 Nov-Dec;10(6):877-86; discussion 886-7
references.pmid: 1661607
references.citation: Int J Cancer. 2010 Dec 1;127(11):2732-5
references.pmid: 20178100
references.citation: Transplantation. 2005 Jan 27;79(2):244-7
references.pmid: 15665775